We also demonstrate that dual inhibition of HDAC1 and LSD1 with the orally bioavailable epigenetic modulator 4SC-202 in the highly metastatic murine model of TNBC 4T1 reduces tumor burden. The gene discussed is KDM1A; the disease is neoplasm.